Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.200
-0.030 (-1.35%)
Apr 28, 2026, 4:15 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 819.47 million as of April 28, 2026. Its market cap has decreased by -1.27% in one year.
Market Cap
819.47M
Enterprise Value
1.39B
Revenue
767.82M
Ranking
n/a
PE Ratio
58.64
Stock Price
2.20
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 819.47M, an increase of 210.68%. That is a compound annual growth rate of 11.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 819.47M | -13.44% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 10.04B |
| Healius | 384.85M |
| Australian Clinical Labs | 363.08M |
| Monash IVF Group | 284.43M |
| Rhythm Biosciences | 61.93M |
| Cryosite | 51.25M |
| INOVIQ | 46.46M |
| Microba Life Sciences | 43.85M |